Related Experiment Video
Updated: Jun 18, 2025
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Evaluating Therapy and Growth in Children with Phenylketonuria: A Retrospective Longitudinal Study from Two Romanian
Meda-Ada Bugi1,2,3, Iulius Jugănaru2,4,5, Iulia-Elena Simina6
1Ph.D. School Department, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
Insights
Phenylketonuria (PKU) patients showed lower weight-for-age z-scores despite normal growth metrics. This suggests PKU dietary management may need adjustments for optimal growth outcomes in children.
Area of Science:
- Metabolic disorders
- Pediatric growth and development
- Nutritional science
Background:
- Phenylketonuria (PKU) is a rare genetic disorder affecting phenylalanine metabolism.
- Early dietary intervention is crucial for preventing PKU complications.
- Growth attainment in PKU patients remains a subject of ongoing research and debate.
Purpose of the Study:
- To compare growth parameters in PKU patients versus healthy controls.
- To evaluate the effectiveness of current dietary management on growth in PKU.
- To identify potential areas for optimizing growth outcomes in PKU.
Main Methods:
- Comparative study involving 18 PKU patients and 18 matched controls from Romanian centers.
- Growth metrics (weight-for-height, weight-for-age, height/length-for-age, BMI-for-age z-scores) assessed from birth to three years.
- Statistical analysis of growth data over a median follow-up of 36 months.
Main Results:
- All four growth metrics remained within normal ranges for both groups.
- PKU patients exhibited significantly lower weight-for-age z-scores throughout most of the study period (p < 0.001).
- Median follow-up was 36 months, with no significant difference in gender distribution.
Conclusions:
- Persistent lower weight-for-age z-scores in PKU patients indicate potential growth challenges.
- Continuous monitoring of growth is essential for PKU management.
- Dietary therapy adjustments may be necessary to optimize growth in individuals with PKU.
Abstract:
Background and Objectives: Phenylketonuria (PKU) is a rare genetic disorder characterized by the inability to convert the essential amino acid phenylalanine into tyrosine. Early dietary treatment can successfully prevent complications, but controversies still exist regarding the attainment of normal growth in these patients. Materials and Methods: Eighteen patients with PKU from two Romanian reference centers were compared to eighteen non-PKU controls, matched for age and gender. The comparisons used weight-for-height, weight-for-age, height/length-for-age, and body mass index-for-age z-scores from birth to three years of age. Results: The PKU study group consisted of nine boys and nine girls, with a median follow-up period of thirty-six months (interquartile range = 9.75). While median values of all four growth metrics remained within the normal range across the entire study period, weight-for-age z-scores were significantly lower in PKU patients throughout most of the study (p < 0.001). Conclusions: The persistent lower weight-for-age z-scores of the PKU patients compared to controls indicate that ongoing monitoring and potential adjustments in dietary therapy may be necessary to further optimize growth outcomes.
Related Concept Videos
01:20Inborn Errors of Metabolism
02:20Longitudinal Research
01:10Nature and Nurture
01:21Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:35Pedigree Analysis